a

Facebook

Twitter

Copyright 2019 Dayton DUI.
All Rights Reserved.

9:00 - 17:00

Our Opening Hours Mon. - Fri.

937.318.1384

Call 24/7 - Free Consultation!

Facebook

Twitter

Search
OVI Menu
 

Fairborn Municipal Court’s Vivitrol Drug Court Program Is Certified

Dayton DUI Attorney Charles Rowland > DUI Law  > Drugs & Alcohol  > Fairborn Municipal Court’s Vivitrol Drug Court Program Is Certified

Fairborn Municipal Court’s Vivitrol Drug Court Program Is Certified

The Fairborn Municipal Court’s Vivitrol drug court has received certification.

According to the very good story in the Fairborn Herald,

The Fairborn Municipal Vivitrol Drug Court program aims to teach individuals how to live a drug and alcohol-free life. Those accepted are expected to be able to do so within two years of entering the program. It is broken into four phases, and individuals will begin Vivitrol treatment within the first phase, and possibly discontinuing the drug during or after the fourth phase, depending on the individual. In the first phase, participants are screened a minimum of two times per week, visit with the probation officer at least once per week and attend status hearing at the courts twice per month. Phase one lasts 12 weeks, and in order for participants to move on to stage two they must pass the screens for eight consecutive weeks, attend all required appointments and be compliant with court and community control/probation orders.

Phase two highlights drug and mental health counseling by targeting the issues that caused them to begin using drugs in the first place and what complications it has caused them since. Participants will still be screened a minimum of two times per week, attend weekly probation appointments as well as status hearings at the court two times per month. They will additionally attend chemical dependency and mental health counseling per their individual treatment plan. Participants will learn to identify relapse triggers and must begin to develop healthy coping mechanisms. In order to move on to the next stage, participants must have clean drug screens for 12 consecutive weeks, continue following orders and attending meetings.

The third phase aims at action, as participants will have less appointments to attend and will begin applying what they have learned through the program in their day-to-day functions. It lasts 12 weeks, and participants are pushed to start working toward their goals, such as finding employment or enrolling in school, which will vary on a case-by-case basis. Participants must undergo one screen per week, one probation appointment every other week depending on their progress as well as mental health and chemical dependency counseling according to their individual plans. Participants will attend court hearings once per month. In order to start the final phase, participants must have clean drug screens for 12 consecutive weeks, be compliant with all court orders and probation rules and attend all appointments.

The fourth and final phase focuses on continuation, as participants will have even fewer appointments to attend and will keep working toward their goals. They will be screened twice per month, attend probation appointments every three to four weeks, see the judge once per month and have chemical dependency counseling according to their individualized treatment plans. In order to begin aftercare, they must have clean drug screens for the remaining five months, complete a relapse prevention plan, attend all required appointments and continue to follow court orders and probation rules.

The program then monitors participants for six months following completion, by meeting with the probation officer on a monthly basis and choosing whether or not to continue counseling and court status hearings.

Naltrexone reverses the effects of opioids and is used primarily in the management of alcohol dependence and opioid dependence. It is marketed in generic form as its hydrochloride salt, naltrexone hydrochloride, and marketed under the trade names Revia and Depade. In some countries, including the United States, a once-monthly extended-release injectable formulation is marketed under the trade name Vivitrol. [Wiki].

Vivitrol Drug CourtThe program is expected to receive final certification from the Ohio Supreme Court Specialized Docket Division following an inspection and observation after the program has begun. People referred to the Vivitrol drug court would be assessed by the judge, defense counsel, prosecutor and probation officer.  To be in the program, the defendant will be required to take Vivitrol. Once admitted, they meet with the probation officer for a risk assessment, then a drug and alcohol and mental health assessment. At that point, the treatment team would review the individual’s assessments results and would discuss if the individual would be a good candidate for the Vivitrol drug court program.

Charles Rowland

charlie@daytondui.com

Charles M. Rowland II has been representing the accused drunk driver for over 20 years. Contact him at (937) 318-1384 if you find yourself facing a DUI (now called OVI) charge.

No Comments

Leave a Comment